Logo image of SBT

STERLING BANCORP INC/MI (SBT) Stock Fundamental Analysis

NASDAQ:SBT - Nasdaq - US85917W1027 - Common Stock - Currency: USD

4.61  -0.04 (-0.86%)

After market: 4.61 0 (0%)

Fundamental Rating

1

SBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 405 industry peers in the Banks industry. The financial health of SBT is average, but there are quite some concerns on its profitability. SBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SBT had positive earnings in the past year.
In the past year SBT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SBT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: SBT reported negative operating cash flow in multiple years.
SBT Yearly Net Income VS EBIT VS OCF VS FCFSBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of SBT (0.25%) is worse than 86.68% of its industry peers.
With a Return On Equity value of 1.80%, SBT is not doing good in the industry: 87.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROIC N/A
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
SBT Yearly ROA, ROE, ROICSBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 10.19%, SBT is doing worse than 83.92% of the companies in the same industry.
In the last couple of years the Profit Margin of SBT has declined.
The Operating Margin and Gross Margin are not available for SBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 10.19%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
SBT Yearly Profit, Operating, Gross MarginsSBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

4

2. Health

2.1 Basic Checks

SBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SBT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SBT has been increased compared to 5 years ago.
There is no outstanding debt for SBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SBT Yearly Shares OutstandingSBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SBT Yearly Total Debt VS Total AssetsSBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

There is no outstanding debt for SBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC20.19%
SBT Yearly LT Debt VS Equity VS FCFSBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBT Yearly Current Assets VS Current LiabilitesSBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SBT have decreased strongly by -72.21% in the last year.
The earnings per share for SBT have been decreasing by -40.74% on average. This is quite bad
SBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
The Revenue for SBT have been decreasing by -15.36% on average. This is quite bad
EPS 1Y (TTM)-72.21%
EPS 3Y-55.42%
EPS 5Y-40.74%
EPS Q2Q%-77.3%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SBT Yearly Revenue VS EstimatesSBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
SBT Yearly EPS VS EstimatesSBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SBT is valuated quite expensively with a Price/Earnings ratio of 115.25.
88.69% of the companies in the same industry are cheaper than SBT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.63. SBT is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 32.60, which means the current valuation is very expensive for SBT.
79.90% of the companies in the same industry are cheaper than SBT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, SBT is valued a bit more expensive.
Industry RankSector Rank
PE 115.25
Fwd PE 32.6
SBT Price Earnings VS Forward Price EarningsSBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBT indicates a rather expensive valuation: SBT more expensive than 82.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 192.3
EV/EBITDA N/A
SBT Per share dataSBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.88
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STERLING BANCORP INC/MI

NASDAQ:SBT (2/21/2025, 8:00:01 PM)

After market: 4.61 0 (0%)

4.61

-0.04 (-0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners26.89%
Inst Owner Change0.4%
Ins Owners2.48%
Ins Owner Change-0.12%
Market Cap241.15M
Analysts80
Price TargetN/A
Short Float %1.62%
Short Ratio10.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-6.42%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-7.35%
Max Revenue beat(4)-2.83%
Revenue beat(8)1
Avg Revenue beat(8)-4.4%
Revenue beat(12)2
Avg Revenue beat(12)-4.24%
Revenue beat(16)4
Avg Revenue beat(16)-3.14%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 115.25
Fwd PE 32.6
P/S 4.07
P/FCF 192.3
P/OCF 163.71
P/B 0.72
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)0.04
EY0.87%
EPS(NY)0.14
Fwd EY3.07%
FCF(TTM)0.02
FCFY0.52%
OCF(TTM)0.03
OCFY0.61%
SpS1.13
BVpS6.4
TBVpS6.37
PEG (NY)2.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.19%
GM N/A
FCFM 2.12%
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 20.07%
Cap/Sales 0.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 20.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC20.19%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.21%
EPS 3Y-55.42%
EPS 5Y-40.74%
EPS Q2Q%-77.3%
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.99%
OCF growth 3YN/A
OCF growth 5YN/A